PASW — Ping An Biomedical Co Cashflow Statement
0.000.00%
Last trade - 00:00- $3.26m
- $4.53m
- CNY34.15m
Annual cashflow statement for Ping An Biomedical Co, fiscal year end - September 30th, CNY millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.21 | 7.23 | -0.994 | -1.28 | -12.8 |
| Depreciation | |||||
| Non-Cash Items | 2.05 | 0.246 | 0.406 | 0.785 | 8.57 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -38.7 | 14 | -5.53 | 15.1 | -2.17 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -31.4 | 21.5 | -6.08 | 14.6 | -6.43 |
| Capital Expenditures | -0.027 | -0.025 | 0 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -10.5 | -3.37 | 15 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.027 | -10.6 | -3.37 | 15 | 0 |
| Financing Cash Flow Items | 25.3 | -16.5 | -9.6 | -0.322 | -31.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31.4 | -9.86 | 8.87 | -30.1 | 43.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.053 | 1.06 | -0.575 | -0.461 | 36.6 |